<DOC>
	<DOCNO>NCT02052986</DOCNO>
	<brief_summary>The investigator aim test hypothesis dietary supplementation VASCAZEN correct omega-3 deficiency cardiac rehab patient improve biochemical risk factor .</brief_summary>
	<brief_title>An Open-Label Study Vascazen Cardiac Rehab Patients With Deficient Blood Omega-3 Fatty Acid Levels</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>Adult subject ( &gt; = 18 year age ) Enrolled Cardiac Rehabilitation clinic document cardiovascular disease assess principle investigator Has cardiovascular examination within past 2 month Subjects refuse provide write consent Subjects medical condition , determine principal investigator , prevent study participation Subjects know bleed clot disorder Subjects know allergy fish Subjects implantable cardiac defibrillator Subjects heart transplant Female subject currently take hormone replacement therapy Subjects pregnant plan become pregnant Subjects currently take Omega3 fatty acid supplement ( either medical supervision selfadministered )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Fatty Acids , Omega-3</keyword>
	<keyword>Omega-3 fatty acid</keyword>
	<keyword>Docosahexaenoic acid ( DHA )</keyword>
	<keyword>Eicosapentaenoic acid ( EPA )</keyword>
	<keyword>Docosapentaenoic acid ( DPA )</keyword>
	<keyword>Omega Index</keyword>
	<keyword>Omega Score</keyword>
	<keyword>Cardiac Rehab</keyword>
</DOC>